Back to results
US 2012/0252777 A1Published application
Thiazolopyrimidine compounds
AssigneeHoffmann-La Roche Inc.
InventorsJohannes Cornelius Hermann, Lee Edwin Lowrie, JR., Matthew C. Lucas, Kin-Chun Thomas Luk, Fernando Padilla, Jutta Wanner, Wenwei Xie, Xiaohu Zhang
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of novel pyrrolopyrazine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
Claims22
A compound of Formula I
- wherein:
- R1 is phenyl, optionally substituted with one or more lower alkyl, lower haloalkyl, hydroxy, hydroxy lower alkyl, lower alkoxy, lower alkyl sulfonyl, halo, nitro, amino, aminoalkyl, amido, cyano, oxo, or R1′;
- R1′ is heterocycloalkyl or spiro heterocycloalkyl, each optionally substituted with one or more R1″;
- R1″ is hydroxy, halo, lower alkyl, lower alkoxy, or lower haloalkyl;
- B is phenyl, pyridinyl, pyrrolidinyl, or piperidinyl;
- X is OH, lower alkoxy, NHC(═O)Y, C(═O)NH2, C(═O)NHY, C(═O)X′, C(═O)Y, CH2NHY, CH2CH2Y, CF═CHY, CH═CHY, CH2OH, C(═O)NHCH2CH2N(CH3)2, or C(═O)NHCH2CH2Y;
- X′ is OH or lower alkoxy;
- Y is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, each optionally substituted with one or more Y3;
- Y3 is hydroxy, lower alkyl, lower alkoxy, halo, oxo, lower haloalkyl, hydroxy lower alkyl, amino, amido, C(═O)NH(CH3), C(═O)OH, C(═O)OY4, or heteroaryl optionally substituted by with one or more lower alkyl, oxo or SH;
- Y4 is lower alkyl;
- or a pharmaceutically acceptable salt thereof.
8 more elements
Dependencies are inferred from the claim text.